Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
Avram Fraint,1 Padmaja Vittal,2 Cynthia Comella2 1Department of Neurological Sciences, 2Section of Movement Disorders, Rush University Medical Center, Chicago, IL, USA Introduction: Botulinum toxin (BoNT) is the treatment of choice for many neurologic movement disorders, including blepharospasm, h...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016-02-01
|
| Seri Bilgileri: | Therapeutics and Clinical Risk Management |
| Konular: | |
| Online Erişim: | https://www.dovepress.com/considerations-on-patient-related-outcomes-with-the-use-of-botulinum-t-peer-reviewed-article-TCRM |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|